4D-710 in Adult Patients With Cystic Fibrosis
This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis.
18 years and older [+14]
Any prior gene therapy for any indication (Exception: mRNA-based or antisense ol... [+16]